ParkLaine partnered with Oxford BioDynamics Plc to deliver a state-of-the-art headquarters in Oxford, encompassing 25,000 sq ft of specialist laboratories, offices, meeting rooms, and breakout areas.
This fast-growing biotechnology company, known for its proprietary EpiSwitch® epigenetic biomarker discovery platform, required a high-quality, energy-efficient, and future-proofed facility to support its expanding team and cutting-edge research. Despite challenges posed by the global pandemic and a tight 20-week timeline, ParkLaine successfully completed the turn-key design and build project, ensuring minimal disruption to ongoing operations.